company background image
HSKA

HeskaNasdaqCM:HSKA Stock Report

Last Price

US$143.48

Market Cap

US$1.5b

7D

-9.8%

1Y

-14.0%

Updated

19 Jan, 2022

Data

Company Financials +
HSKA fundamental analysis
Snowflake Score
Valuation1/6
Future Growth3/6
Past Performance1/6
Financial Health4/6
Dividends0/6

HSKA Stock Overview

Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland.

Heska Competitors

IDEXX Laboratories

NasdaqGS:IDXX

US$44.0b

Samsung Electronics

KOSE:A005930

₩513.6t

Merck

NYSE:MRK

US$205.3b

Sanofi

ENXTPA:SAN

€115.1b

Price History & Performance

Summary of all time highs, changes and price drops for Heska
Historical stock prices
Current Share PriceUS$143.48
52 Week HighUS$275.94
52 Week LowUS$142.10
Beta1.56
1 Month Change-14.72%
3 Month Change-39.08%
1 Year Change-13.96%
3 Year Change49.01%
5 Year Change78.26%
Change since IPO66.35%

Recent News & Updates

Jan 09
Heska (NASDAQ:HSKA) Has A Rock Solid Balance Sheet

Heska (NASDAQ:HSKA) Has A Rock Solid Balance Sheet

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...

Dec 13
Estimating The Fair Value Of Heska Corporation (NASDAQ:HSKA)

Estimating The Fair Value Of Heska Corporation (NASDAQ:HSKA)

Today we'll do a simple run through of a valuation method used to estimate the attractiveness of Heska Corporation...

Shareholder Returns

HSKAUS Medical EquipmentUS Market
7D-9.8%-4.8%-4.6%
1Y-14.0%-0.4%7.7%

Return vs Industry: HSKA underperformed the US Medical Equipment industry which returned 0.8% over the past year.

Return vs Market: HSKA underperformed the US Market which returned 10.2% over the past year.

Price Volatility

Is HSKA's price volatile compared to industry and market?
HSKA volatility
HSKA Average Weekly Movement8.1%
Medical Equipment Industry Average Movement8.2%
Market Average Movement6.6%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market2.4%

Stable Share Price: HSKA is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 8% a week.

Volatility Over Time: HSKA's weekly volatility (8%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1988602Kevin Wilsonhttps://www.heska.com

Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Mexico, Australia, France, Germany, Italy, Malaysia, Spain, and Switzerland. The company offers Element DC and Element DC5x veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element HT5 and scil Vet abc Plus +TM veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; Element COAG veterinary analyzers; and IV infusion pumps. It also provides digital radiography hardware and mobile digital radiography products, as well as ultrasound systems; Cloudbank, a Web-based image storage solution; HeskaView, a picture archival and communications system for Cloudbank; point-of-care heartworm diagnostic test products for dogs and cats; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and treatment and control of ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops.

Heska Fundamentals Summary

How do Heska's earnings and revenue compare to its market cap?
HSKA fundamental statistics
Market CapUS$1.54b
Earnings (TTM)US$1.87m
Revenue (TTM)US$249.99m

821.4x

P/E Ratio

6.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
HSKA income statement (TTM)
RevenueUS$249.99m
Cost of RevenueUS$145.43m
Gross ProfitUS$104.56m
ExpensesUS$102.69m
EarningsUS$1.87m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)0.17
Gross Margin41.83%
Net Profit Margin0.75%
Debt/Equity Ratio23.0%

How did HSKA perform over the long term?

See historical performance and comparison

Valuation

Is Heska undervalued compared to its fair value and its price relative to the market?

12.0%

Undervalued compared to fair value


Share Price vs. Fair Value

Below Fair Value: HSKA ($143.48) is trading below our estimate of fair value ($163.05)

Significantly Below Fair Value: HSKA is trading below fair value, but not by a significant amount.


Price To Earnings Ratio

PE vs Industry: HSKA is poor value based on its PE Ratio (821.4x) compared to the US Medical Equipment industry average (46.7x).

PE vs Market: HSKA is poor value based on its PE Ratio (821.4x) compared to the US market (17x).


Price to Earnings Growth Ratio

PEG Ratio: HSKA is poor value based on its PEG Ratio (19.6x)


Price to Book Ratio

PB vs Industry: HSKA's PB Ratio (3.5x) is in line with the US Medical Equipment industry average.


Future Growth

How is Heska forecast to perform in the next 1 to 3 years based on estimates from 6 analysts?

42.0%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: HSKA's forecast earnings growth (42% per year) is above the savings rate (2%).

Earnings vs Market: HSKA's earnings (42% per year) are forecast to grow faster than the US market (13% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: HSKA's revenue (8% per year) is forecast to grow slower than the US market (9.2% per year).

High Growth Revenue: HSKA's revenue (8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: HSKA's Return on Equity is forecast to be low in 3 years time (7%).


Past Performance

How has Heska performed over the past 5 years?

-61.0%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: HSKA has a large one-off loss of $7.6M impacting its September 30 2021 financial results.

Growing Profit Margin: HSKA became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: HSKA's earnings have declined by 61% per year over the past 5 years.

Accelerating Growth: HSKA has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: HSKA has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (51.2%).


Return on Equity

High ROE: HSKA's Return on Equity (0.4%) is considered low.


Financial Health

How is Heska's financial position?


Financial Position Analysis

Short Term Liabilities: HSKA's short term assets ($311.6M) exceed its short term liabilities ($37.9M).

Long Term Liabilities: HSKA's short term assets ($311.6M) exceed its long term liabilities ($124.4M).


Debt to Equity History and Analysis

Debt Level: HSKA has more cash than its total debt.

Reducing Debt: HSKA's debt to equity ratio has increased from 2.2% to 23% over the past 5 years.

Debt Coverage: HSKA's debt is not well covered by operating cash flow (12.7%).

Interest Coverage: HSKA's interest payments on its debt are well covered by EBIT (11.3x coverage).


Balance Sheet


Dividend

What is Heska current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate HSKA's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate HSKA's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if HSKA's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if HSKA's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: HSKA is not paying a notable dividend for the US market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of HSKA's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

2.1yrs

Average management tenure


CEO

Kevin Wilson (49 yo)

8.92yrs

Tenure

US$1,711,171

Compensation

Mr. Kevin S. Wilson has been President of Heska Corporation since February 24, 2013. Mr. Wilson has been Chief Executive Officer of Heska Corporation since March 31, 2014. He served as Chief Operating Offi...


CEO Compensation Analysis

Compensation vs Market: Kevin's total compensation ($USD1.71M) is below average for companies of similar size in the US market ($USD3.70M).

Compensation vs Earnings: Kevin's compensation has been consistent with company performance over the past year.


Leadership Team

Experienced Management: HSKA's management team is considered experienced (2.1 years average tenure).


Board Members

Experienced Board: HSKA's board of directors are considered experienced (3.7 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: HSKA insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 13.3%.


Top Shareholders

Company Information

Heska Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: Heska Corporation
  • Ticker: HSKA
  • Exchange: NasdaqCM
  • Founded: 1988
  • Industry: Health Care Equipment
  • Sector: Healthcare
  • Implied Market Cap: US$1.537b
  • Shares outstanding: 10.71m
  • Website: https://www.heska.com

Number of Employees


Location

  • Heska Corporation
  • 3760 Rocky Mountain Avenue
  • Loveland
  • Colorado
  • 80538
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2022/01/19 23:31
End of Day Share Price2022/01/19 00:00
Earnings2021/09/30
Annual Earnings2020/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.